E Fund Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$688K Buy
+20,706
New +$617K 0.02% 221
2025
Q2
$756K Buy
21,009
+4,013
+24% +$149K 0.04% 191
2025
Q1
$670K Sell
16,996
-6,558
-28% -$221K 0.03% 197
2024
Q4
$709K Buy
23,554
+1,711
+8% +$49.1K 0.04% 187
2024
Q3
$511K Buy
21,843
+1,378
+7% +$30.1K 0.03% 193
2024
Q2
$364K Sell
20,465
-5,361
-21% -$85.5K 0.02% 208
2024
Q1
$393K Sell
25,826
-4,727
-15% -$75.3K 0.02% 226
2023
Q4
$522K Sell
30,553
-13,457
-31% -$156K 0.03% 154
2023
Q3
$368K Buy
44,010
+27,744
+171% +$387K 0.03% 181
2023
Q2
$404K Sell
16,266
-11,162
-41% -$288K 0.03% 164
2023
Q1
$413K Sell
27,428
-11,965
-30% -$182K 0.03% 155
2022
Q4
$466K Sell
39,393
-13,757
-26% -$99.8K 0.04% 141
2022
Q3
$315K Sell
53,150
-16,955
-24% -$111K 0.03% 229
2022
Q2
$298K Buy
70,105
+39,622
+130% +$247K 0.03% 235
2022
Q1
$290K Buy
30,483
+20,017
+191% +$232K 0.01% 205
2021
Q4
$199K Buy
+10,466
New +$272K 0.01% 265

Other funds holding TGTX